CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity

Journal of Immunology

Volumn 176, Issue 3, 2006, Pages 1517-1524

  Hayakawa, Yoshihiro ^a   Smyth, Mark J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; CD56 ANTIGEN; CELL MARKER; CHEMOKINE; LEUKOSIALIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOREACTIVITY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 31144449386     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.3.1517     Document Type: Article

References (43)

1. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
2. Karre, K. 1997. How to recognize a foreign submarine. Immunol. Rev. 155: 5-9.
3. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330.
4. Biron, C. A., and L. Brossay. 2001. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13: 458-464.
5. Trapani, J. A., and M. J. Smyth. 2002. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2: 735-747.
6. Smyth, M. J., K. Takeda, Y. Hayakawa, J. J. Peschon, M. R. van den Brink, and H. Yagita. 2003. Nature's TRAIL: on a path to cancer immunotherapy. Immunity 18: 1-6.
7. Yokoyama, W. M., and B. F. Plougastel. 2003. Immune functions encoded by the natural killer gene complex. Nat Rev. Immunol. 3: 304-316.
8. Smyth, M. J., Y. Hayakawa, K. Takeda, and H. Yagita. 2002. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer 2: 850-861.
9. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1: 41-49.
10. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5: 405-411.
11. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333.
12. Kelly, J. M., P. K. Darcy, J. L. Markby, D. I. Godfrey, K. Takeda, H. Yagita, and M. J. Smyth. 2002. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3: 83-90.
13. low targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19: 561-569.
14. Raulet, D. H. 2004. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5: 996-1002.
15. Degli-Esposti, M. A., and M. J. Smyth. 2005. Close encounters of different kinds: dendritic cells and NK cells take center stage. Nat. Rev. Immunol. 5: 112-124.
16. Moretta, L., G. Ferlazzo, M. C. Mingari, G. Melioli, and A. Moretta. 2003. Human natural killer cell function and their interactions with dendritic cells. Vaccine 21(Suppl. 2): S38-S42.
17. Martin-Fontecha, A., L. L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-γ for T(H)1 priming. Nat. Immunol. 5: 1260-1265.
18. Yokoyama, W. M., S. Kim, and A. R. French. 2004. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22: 405-429.
19. Raulet, D. H. 1999. Development and tolerance of natural killer cells. Curr. Opin. Immunol. 11: 129-134.
20. Colucci, F., M. A. Caligiuri, and I. P. Di Santo. 2003. What does it take to make a natural killer? Nat. Rev. Immunol. 3: 413-425.
21. Perussia, B., Y. Chen, and M. J. Loza. 2005. Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell. Mol. Immunol. 42: 385-395.
22. Kim, S., K. Iizuka, H. S. Kang, A. Dokun, A. R. French, S. Greco, and W. M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3: 523-528.
23. Takeda, K., E. Cretney, Y. Hayakawa, T. Ota, H. Akiba, K. Ogasawara, H. Yagita, K. Kinoshita, K. Okumura, and M. J. Smyth. 2005. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105: 2082-2089.
24. Lanier, L. L., A. M. Le, J. H. Phillips, N. L. Warner, and G. F. Babcock. 1983. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol. 131: 1789-1796.
25. bright+ natural killer cell subpopulations. Int. Arch. Allergy Immunol. 110: 308-313.
26. dim natural killer cell subsets. J. Immunol. 161: 400-408.
27. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22: 633-640.
28. Hayakawa, Y., V. Screpanti, H. Yagita, A. Grandien, H. G. Ljunggren, M. J. Smyth, and B. J. Chambers. 2004. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J. Immunol. 172: 123-129.
29. + T lymphocytes. J. Immunol. 168: 65-72.
30. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
31. Takeda, K., H. Oshima, Y. Hayakawa, H. Akiba, M. Atsuta, T. Kobata, K. Kobayashi, M. Ito, H. Yagita, and K. Okumura. 2000. CD27-mediated activation of murine NK cells. J. Immunol. 164: 1741-1745.
32. Dorfman, J. R., and D. H. Raulet. 1998. Acquisition of Ly49 receptor expression by developing natural killer cells. J. Exp. Med. 187: 609-618.
33. Roth, C., J. R. Carlyle, H. Takizawa, and D. H. Raulet. 2000. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity 13: 143-153.
34. Prlic, M., B. R. Blazar, M. A. Farrar, and S. C. Jameson. 2003. In vivo survival and homeostatic proliferation of natural killer cells. J. Exp. Med. 197: 967-976.
35. Jamieson, A. M., P. Isnard, J. R. Dorfman, M. C. Coles, and D. H. Raulet. 2004. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 172: 864-870.
36. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 173: 6418-6426.
37. Voehringer, D., C. Blaser, P. Brawand, D. H. Raulet, T. Hanke, and H. Pircher. 2001. Viral infections induce abundant numbers of senescent CD8 T cells. J. Immunol. 167: 4838-4843.
38. 1 molecule during the activation of mouse NK cells. J. Immunol. 168: 2585-2589.
39. - natural killer cells is selectively responsible for both cell proliferation and interfeton-γ production upon interaction with dendritic cells. Eur. J. Immunol. 34: 1715-1722.
40. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61: 246-257.
41. + T-cell maturation: CD27 might provide a clue. Trends Immunol. 23: 586-591.
42. McHeyzer-Williams, L. J., and M. G. McHeyzer-Williams. 2005. Antigen-specific memory B cell development. Annu. Rev. Immunol. 23: 487-513.
43. Nolte, M. A., R. Arens, R. van Os, M. van Oosterwijk, B. Hooibrink, R. A. van Lier, and M. H. van Oers. 2005. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nat. Immunol. 6: 412-418.